Radial vs. Femoral Access for Cardiac Catheterization Complications
(REBIRTH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods for cardiac catheterization, a procedure to assess heart health. It compares the radial approach, which uses the wrist, with the femoral approach, which uses the groin. The femoral approach further divides into using either an 18-gauge needle or a 21-gauge needle. The trial aims to determine which method results in fewer complications for individuals without a specific type of heart attack. Participants should experience heart-related symptoms and require a heart procedure but must not have had a recent severe heart attack. As an unphased trial, this study allows participants to contribute to important research that could enhance cardiac care techniques.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking oral factor Xa or IIa inhibitors, you should not have taken them within 24 hours before the procedure.
What is the safety track record for these treatments?
Research shows that using the wrist (radial access) for heart procedures is generally safe. The most common issue is a 5% chance of artery blockage in the wrist, which is usually not serious. Serious problems, such as a tear in the artery or a painful condition from pressure buildup, are rare. The wrist method also results in less bleeding compared to the groin (femoral access).
For the groin method, even with the latest techniques, sources do not highlight specific safety concerns. However, advanced tools like ultrasound and special devices can enhance safety.
Overall, both wrist and groin methods have been successfully used in many patients. Each has its own risks, but they are generally well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it compares two different techniques for cardiac catheterization—radial access and femoral access. Radial access stands out due to its use of ultrasound guidance and a micropuncture needle or a catheter-over-needle system, which can potentially lead to fewer complications and quicker recovery times compared to traditional femoral access. On the other hand, the femoral access technique is being evaluated with state-of-the-art enhancements like ultrasound and fluoroscopic guidance, immediate angiography after arterial access, and the use of a vascular closure device, all of which aim to improve safety and outcomes. By comparing these advanced techniques, the study seeks to determine which approach minimizes complications and enhances patient recovery.
What evidence suggests that this trial's access methods could be effective for cardiac catheterization?
Research has shown that using the wrist (radial access) for cardiac catheterization is highly effective, achieving a success rate of over 90% for diagnostic procedures. In this trial, participants will undergo either radial access or femoral access for their procedure. Studies have found that radial access significantly reduces bleeding compared to groin (femoral) access. Regarding safety, the risk of death within 30 days is similar for both methods. Both approaches are effective and offer distinct benefits, but wrist access might slightly lower the risk of certain complications.34678
Who Is on the Research Team?
Emmanouil Brilakis, MD, PhD
Principal Investigator
Minneapolis Heart Institute Foundation
Are You a Good Fit for This Trial?
Adults over 18 eligible for cardiac catheterization via both radial and femoral access, who consent to participate. Suitable for those needing diagnostic angiography or urgent/elective PCI, but not for patients with recent oral anticoagulant use, peripheral arterial disease affecting access sites, limited life expectancy, certain heart conditions or procedures within the next month.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cardiac catheterization using either radial or state-of-the-art femoral access
Follow-up
Participants are monitored for safety and effectiveness after the procedure, including evaluations of myocardial infarction and procedural success
What Are the Treatments Tested in This Trial?
Interventions
- Radial Access
- State-of-the-art femoral access with 18 gauge needle
- State-of-the-art femoral access with 21 gauge needle
Find a Clinic Near You
Who Is Running the Clinical Trial?
Minneapolis Heart Institute Foundation
Lead Sponsor